ABH Healthcare opens US$4.75M IPO amid strong grey market demand
What's the deal? ABH HealthcareDealroom has a profile for this one. Try Dealroom →, a Mumbai-based multi-specialty healthcare provider, opened its initial public offering on August 24, aiming to raise US$4.75M. The company priced shares between US$1.3 and US$1.39 and plans to list on the NSEDealroom has a profile for this one. Try Dealroom → SME platform.
The details: The offering is a fresh issue of 3,429,600 equity shares, with subscription open until August 27. Retail investors must bid for a minimum of two lots, or 2,400 shares — about US$3.33K at the top price.
What's the endgame? ABH Healthcare will use roughly US$2.31M of the proceeds for debt repayment and about US$679K for working capital. The rest is earmarked for potential acquisitions and general corporate purposes.
Why now? India's healthcare sector has grown sharply, driven by rising demand for specialised medical services and wider access to treatment. Companies in the multi-specialty segment are expanding capacity to meet that demand.
What could go wrong? Shares are trading at an unofficial grey market premium of US$0.37 to US$0.41, implying a possible listing gain of nearly 26.5% to 29.4%. Market experts caution that grey market trends are unofficial and do not guarantee actual listing performance.
The signal: ABH Healthcare's listing reflects steady appetite for smaller healthcare offerings on India's SME exchanges, where investor interest in the sector continues to build.
Read more: deshwale.com
Image credit: Andreanna Moya Photography
